Skip to search boxSkip to navigationSkip to main content

B-cell recovery following rituximab-based therapy is associated with perturbations in stromal derived factor-1 and granulocyte homeostasis

  • Kieron Dunleavy
    ,
  • Frances Hakim
    ,
  • Hyun Kyung Kim
    ,
  • John E. Janik
    ,
  • Nicole Grant
    ,
  • Takayuki Nakayama
*Corresponding author for this work
  • Unknown
    ,
  • National Institutes of Health
Scholary Output:
Contribution to journal
Article
Research
Peer-review

Open access

Abstract

<p>The occurrence of delayed neutropenia following rituximab is poorly defined and of unknown cause. We hypothesized it may be related to perturbations of stromal derived factor-1 (SDF-1) and granulocyte homeostasis. Late-onset neutropenia (LON) was investigated in 130 patients with untreated aggressive B-cell lymphoma receiving DA-EPOCH (dose-adjusted etoposide, prednisone, Oncovin [vincristine], cyclophosphamide, and hydroxydaunorubicin) chemotherapy with or without rituximab. All patients were in remission and had no known causes for neutropenia. LON occurred in 6 (8%) of 76 patients receiving rituximab and 0 of 54 patients not receiving rituximab (P = .04). The median onset was 175 days (range, 77-204 days) after treatment with a median duration of 14 days (range, 11-16 days). In a subset of 24 patients, a significant correlation was found between rapid B-cell recovery and granulocyte decline over the 6-month recovery period (R = -0.53; P = .04). Rapid B-cell recovery directly correlated with prerecovery SDF-1 levels (R = 0.65; P = .015) and SDF-1 decline (R = -0.67; P = .013) after recovery. Our results suggest that early B-cell lymphopoiesis is important for B-cell recovery following rituximab, and that perturbation of SDF-1 during B-cell recovery retards neutrophil egress from the bone marrow. These findings illustrate the dual role of SDF-1 in human B-cell and granulocyte homeostasis.</p>

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Research
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 795-802 (8 pages)

Journal (Volume, Issue Number)

Blood (Volume 106, Issue 3)

Publication milestones

  • Published - 08/01/2005

Publication status

Published - 08/01/2005

ISSN

0006-4971

Publication IDs

  • Scopus: 23044502336
  • PubMed: 15718416

Publication metrics

Metrics

SciVal
citations
84
SciVal
FWCI
1.62
SciVal
Author count
12
SciVal
Paper percentile
93
SciVal
Top percentile
10
Fractional count
1
Fractional count
0.08
Fractional count
11
Fractional count
0.92
Fractional count
1
Fractional count
1
Scopus
citations

PlumX, opens in new tab

Citation count
120
Captures
61

Funding Details

FunderFunding number
NCI
ZIABC010728